Licated in crosstalk with other pathways and resistance to chemotherapy, and
Licated in crosstalk with other pathways and resistance to chemotherapy, and it can be ubiquitously expressed, we will continue to view anti-IGF-1R therapy becoming combined with other therapeutic agents in…